1 Answers

Pertuzumab is a HER2/neu receptor antagonist indicated for:

Use in combination with trastuzumab and docetaxel for treatment of patients with HER2-positive metastatic breast cancer (MBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

 

Use in combination with trastuzumab and chemotherapy as:

  • Neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer.
  • Adjuvant treatment of patients with HER2-positive early breast cancer at high risk of recurrence

Pertuza Injection সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Pertuza

3364 views